重新评估评估在Ileal与结肠克罗恩病的反应差异的方法:FITZROY试验的后期分析
Christopher Ma1,2,3, Brian G Feagan3,4,5, Zhongya Wang3
1Division of Gastroenterology & Hepatology, University of Calgary, Calgary, AB, Canada.
菲尔戈提尼布在以叶叶主导和孤立的结肠克罗恩病中表现出类似的疗效. 这种Janus激酶抑制剂在考虑基线活性和患者因素时有效地治疗了这两种疾病位置.
科学领域:
- 胃肠病学 胃肠病学
- 免疫学 免疫学 免疫学
- 临床药理学 临床药理学
背景情况:
- 克罗恩氏病 (CD) 常常会影响小肠的最后部分 - - 大肠.
- 克罗恩病中的疾病位置可能会影响治疗反应.
- 菲尔戈提尼布是一种Janus激酶 (JAK) 抑制剂,是适度至严重活性CD的治疗选择.
研究的目的:
- 调查疾病的位置 (伊叶主导与孤立的结肠) 是否会影响filgotinib在克罗恩氏病患者的疗效.
- 用验证的疾病活性指数来比较治疗反应,并考虑阴茎和结肠的测量差异.
主要方法:
- 对FITZROY第二阶段试验数据的后期分析.
- 克罗恩病活动指数 (CDAI) 和克罗恩病简单内镜评分 (SES-CD) 的比较10周内变化.
- 用于重复测量的混合效应模型,用于评估按疾病治疗位置的相互作用.
主要成果:
- 最初,较高的临床缓解率 (CDAI < 150) 和内镜反应 (SES-CD 减少 ≥ 50%) 观察到孤立的结肠CD与阴茎主导的结肠CD.
- 在调整了基线疾病活性和患者聚类后,在伊利尔主导和孤立的结肠病之间没有发现菲尔戈提尼布疗效的显著差异.
- 根据疾病的位置,统计分析显示 ΔCDAI (p=0.85) 或 ΔSES-CD (p=0.48) 的平均变化没有显著差异.
结论:
- 菲尔戈提尼布在患有阴茎主导和隔离结肠克罗恩病的患者中表现出类似的治疗疗效.
- 根据基线疾病活动和聚类效应进行调整对于准确评估不同疾病位置的治疗反应至关重要.
更多相关视频
09:11Systematic Scoring Analysis for Intestinal Inflammation in a Murine Dextran Sodium Sulfate-Induced Colitis Model
Published on: February 14, 2021
15:49Flexible Colonoscopy in Mice to Evaluate the Severity of Colitis and Colorectal Tumors Using a Validated Endoscopic Scoring System
Published on: October 16, 2013
相关概念视频
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Inflammatory Bowel Disease V: Surgical Management
Here are some common surgical interventions for IBD:
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
